No Detail Found!

Pharmacogenomic profile of a Pakistani individual.

Author(s)
Muhammad Ilyas Centre of Excellence in Molecular Biology, University of the Punjab, Lahore – Pakistan;Personal Genomics Institute, Genome Research Foundation, Suwon – South Korea;Department of Biochemistry, Abdul Wali Khan University, Mardan, Pakistan
Ziaur-Rahman Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan
Tayyab Husnain Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan
Jong Bhak Personal Genomics Institute, Genome Research Foundation, Suwon – South Korea;Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan – South Korea
Abstract
The new era of pharmacogenomics has been raised where we use genetic information of an individual for the development of personalised medicine. Here, we analysed the whole genome sequence of a Pakistani individual to get his pharmacogenomics profile. We found a number of SNPs associated with methotrexate dose response, docetaxel and thalidomide, and several other variants of clinical relevance. The current study provides a workflow example to use personal genomes for developing personalised medicine protocols. The pharmacogenomics association to neurological disorders, depression and hypertension discovered here can provide the most fundamental information for a Pakistani individual to change his way of life and carry out precautionary actions for a better life ahead.
Publication Details
Page(s) 183-187
DOI DOI not available
Published Journal: Science, Technology and Development, Volume: 33, Issue: 4, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

35

Views